Ka Ming Yeh1, Olle Johansson2, Huy Le1, Karan Rao1, Irit Markus1, Dayashan Shevy Perera3, David Zachary Lubowski3, Denis Warwick King3, Li Zhang4, Hongzhuan Chen5, Lu Liu6. 1. Department of Pharmacology, Faculty of Medicine, School of Medical Sciences, University of New South Wales, Sydney, NSW, 2052, Australia. 2. Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden. 3. Sydney Colorectal Associates, Sydney, Australia. 4. School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia. 5. School of Medicine, Shanghai Jiao Tong University, Shanghai, China. 6. Department of Pharmacology, Faculty of Medicine, School of Medical Sciences, University of New South Wales, Sydney, NSW, 2052, Australia. Lu.Liu@unsw.edu.au.
Abstract
BACKGROUND: Cystic fibrosis transmembrane conductance regulator (CFTR) was recently found in the enteric nervous system, where its role is unclear. We aimed to identify which enteric neuronal structures express CFTR, whether CFTR modulates enteric neurotransmission and if altered CFTR expression is associated with slow transit constipation (STC). METHODS: Immunofluorescence double labeling was performed to localize CFTR with various neuronal and glial cell markers in the human colon. The immunoreactivity (IR) of CFTR and choline acetyltransferase (ChAT) on myenteric plexus of control and STC colon was quantitatively analyzed. In control colonic muscle strips, electrical field stimulation (EFS) evoked contractile responses and the release of acetylcholine (ACh) was measured in the presence of the CFTR channel inhibitor, CFTR(inh)-172. RESULTS: CFTR-IR was densely localized to myenteric ganglia, where it was co-localized with neuronal markers HuC/D and β-tubulin, and glial marker S-100 but little with glial fibrillary acidic protein. Vesicular ACh transport was almost exclusively co-localized with CFTR, but neurons expressing nitric oxide synthase were CFTR negative. Significant reductions of CFTR-IR (P < 0.01) and ChAT-IR (P < 0.05) were observed on myenteric ganglia of STC compared to control. Pre-treatment of colonic muscle strips with CFTR(inh)-172 (10 µM) significantly inhibited EFS-evoked contractile responses (P < 0.01) and ACh release (P < 0.05). CONCLUSIONS: Co-localization of CFTR-IR with cholinergic markers, inhibition of EFS-induced colonic muscle contractility and ACh release by CFTR(inh)-172 suggest that CFTR modulates enteric cholinergic neurotransmission. The downregulation of CFTR and ChAT in myenteric ganglia of STC correlated with the impaired contractile responses to EFS.
BACKGROUND:Cystic fibrosis transmembrane conductance regulator (CFTR) was recently found in the enteric nervous system, where its role is unclear. We aimed to identify which enteric neuronal structures express CFTR, whether CFTR modulates enteric neurotransmission and if altered CFTR expression is associated with slow transit constipation (STC). METHODS: Immunofluorescence double labeling was performed to localize CFTR with various neuronal and glial cell markers in the human colon. The immunoreactivity (IR) of CFTR and choline acetyltransferase (ChAT) on myenteric plexus of control and STC colon was quantitatively analyzed. In control colonic muscle strips, electrical field stimulation (EFS) evoked contractile responses and the release of acetylcholine (ACh) was measured in the presence of the CFTR channel inhibitor, CFTR(inh)-172. RESULTS:CFTR-IR was densely localized to myenteric ganglia, where it was co-localized with neuronal markers HuC/D and β-tubulin, and glial marker S-100 but little with glial fibrillary acidic protein. Vesicular ACh transport was almost exclusively co-localized with CFTR, but neurons expressing nitric oxide synthase were CFTR negative. Significant reductions of CFTR-IR (P < 0.01) and ChAT-IR (P < 0.05) were observed on myenteric ganglia of STC compared to control. Pre-treatment of colonic muscle strips with CFTR(inh)-172 (10 µM) significantly inhibited EFS-evoked contractile responses (P < 0.01) and ACh release (P < 0.05). CONCLUSIONS: Co-localization of CFTR-IR with cholinergic markers, inhibition of EFS-induced colonic muscle contractility and ACh release by CFTR(inh)-172 suggest that CFTR modulates enteric cholinergic neurotransmission. The downregulation of CFTR and ChAT in myenteric ganglia of STC correlated with the impaired contractile responses to EFS.
Authors: Matthew J Broadhead; Peter O Bayguinov; Takanobu Okamoto; Dante J Heredia; Terence K Smith Journal: J Physiol Date: 2011-11-07 Impact factor: 5.182
Authors: Shivani Sharma; Tina Sharma; Richa Dhingra; Prince Tomar; Sukhminder Singh; Manav Malhotra; T R Bhardwaj Journal: Mini Rev Med Chem Date: 2013-10 Impact factor: 3.862
Authors: J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou Journal: Science Date: 1989-09-08 Impact factor: 47.728
Authors: Patrick Verloo; Clemens H M Kocken; Annemarie Van der Wel; Ben C Tilly; Boris M Hogema; Maarten Sinaasappel; Alan W Thomas; Hugo R De Jonge Journal: J Biol Chem Date: 2003-12-16 Impact factor: 5.157
Authors: Onur Cil; Puay-Wah Phuan; Sujin Lee; Joseph Tan; Peter M Haggie; Marc H Levin; Liang Sun; Jay R Thiagarajah; Tonghui Ma; A S Verkman Journal: Cell Mol Gastroenterol Hepatol Date: 2016-01-09